close
3 mins to read

Trilogy falls out of favour with investors

Trilogy's share price has plunged 56% since an August high. 

Calida Smylie
Wed, 31 May 2017

Trilogy International’s share price has more than halved from its all-time high in August last year, and remained stagnant after it released full-year results last Friday.

The natural skincare and candle company’s share price was on a roll this time last year, reaching a peak of $4.90 in August.

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Calida Smylie
Wed, 31 May 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Trilogy falls out of favour with investors
67390